1,437.29 USD
↗ 5.00 (0.35%)AT CLOSE (03:59 PM EST)
Eli Lilly & Co.
LLYNYSE • USD
1,443.93
↗ 6.63 (0.46%)
POST MARKET (AS OF 05:53 PM EST)
Post Market
AS OF 05:53 PM EST
1,443.93
↗ 6.63 (0.46%)
Market: OPEN
Shares of Eli Lilly & Co. (LLY) are trading at $1,443.93. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, exceptional Return on Equity (68.5%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 11, 2026.
Open?$1,418.08
High?$1,440.47
Low?$1,414.37
Prev. Close?$1,432.29
Volume?1.9M
Avg. Volume?2.8M
VWAP?$1,426.74
Rel. Volume?0.67x
Bid / Ask
Bid?$1,441.56 × 10
Ask?$1,444.00 × 10
Spread?$2.44
Midpoint?$1,442.78
Valuation & Ratios
Market Cap?1275.8B
Shares Out?940.7M
Float?849.7M
Float %?90.3%
P/E Ratio?46.26
P/B Ratio?31.68
EPS?$30.96
Dividend?0.47%
Ex-Dividend?2026-11-13
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
1275.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?60
Short Sent.?84
Piotroski F-Score?4/9Mixed
Altman Z-Score?8.97Safe
Confidence?66%Moderate
Short InterestLow
Short % of Float?0.85%Low
Short Interest?7.2M
Days to Cover?2.7
Free Float849.7M
Avg Daily Volume2.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.39Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.10Low
Debt/Equity?1.23Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?46.3PRICEY▾
Peers44
S&P15
P/B?31.68HIGH▾
Peers10
S&P3
P/S?14.76HIGH▾
Peers10
S&P3
P/FCF?64.9PRICEY▾
Peers10
S&P6
EV/EBITDA?28.4HIGH▾
Peers40
S&P11
EV/Sales?15.27HIGH▾
Peers10
S&P3
Returns & Efficiency
ROE?68.5%STRONG▾
Peers88
S&P94
ROA?18.6%STRONG▾
Peers89
S&P93
Cash Flow & Enterprise
FCF?$19.7B
Enterprise Value?$1320.4B
Fundamentals ratios updated end of day